United States · FDA National Drug Code directory
Cevimeline Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-657_640e50a9-48ba-45e3-a3cb-c14bb313cc4f
- Product NDC
- 16571-657
- Form
- CAPSULE
- Composition / generic term
- Cevimeline Hydrochloride
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140617
- Source listing expiry
- 20261231
Source-listed ingredients
- CEVIMELINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (16571-657-10) · 16571-657-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →